How to Prepare for a Sublocade Treatment Discussion

Understand the approved use before the appointment

Health Canada’s drug database identifies Sublocade as extended-release buprenorphine for subcutaneous administration and links the current product monograph. That monograph—not a blog—controls indications, contraindications, warnings, dosing, administration, and adverse-effect information.

Health Canada’s opioid use disorder treatment page places Sublocade within clinician-provided opioid agonist treatment and describes it as an injection administered by a healthcare provider in a medical setting about every four weeks. It is not a medication for self-injection or a general pain treatment.

A clinician must decide whether it fits a particular person after reviewing current opioid use, other medications and substances, medical history, treatment history, risks, preferences, and the current monograph. Road To Recovery’s Sublocade page confirms a first-party service pathway, but not automatic eligibility or availability at every location.

Step 1 gather an accurate health and medication history

Bring a current list of prescription medicines, non-prescription products, supplements, and substances used. Include what you take, how it is used, the last time it was used when clinically relevant, and the prescriber or pharmacy where appropriate. Do not leave out sedatives, alcohol, opioids, or other substances because the information feels uncomfortable; clinicians need accurate context to assess risk.

Also record allergies, prior reactions, major medical conditions, pregnancy or breastfeeding considerations when relevant, mental-health concerns, previous opioid agonist treatment, and what made earlier plans easier or harder to follow. Bring identification and coverage information only as requested by the clinic.

Step 2 define goals and practical barriers

Write two or three goals in your own words. Examples might concern reducing overdose risk, avoiding withdrawal, creating a more manageable care routine, reconnecting with work or family, or staying engaged with support. These are discussion topics, not promised outcomes.

List barriers that could affect attendance or follow-up: transportation, work hours, caregiving, housing, pharmacy access, phone access, privacy, cost or coverage questions, and past experiences with stigma. Ask which barriers the clinic can address and which require another service or referral.

The Road To Recovery OAT page provides broader first-party program context. Use the locations directory to identify a possible clinic, then confirm the exact service directly.

Step 3 ask clinical and safety questions

1. What assessment is required before Sublocade can be considered?
2. Which current medications or substances create important risks?
3. What must happen before the first healthcare-provider-administered injection?
4. What common and serious effects should be discussed from the current monograph?
5. What follow-up, monitoring, counselling, pharmacy, or laboratory steps may apply?
6. Whom should I contact for a routine concern, urgent concern, missed appointment, or worsening symptoms?
7. What alternatives should we discuss if this option does not fit?

Do not ask a website to turn those questions into personal instructions. CPSO’s current prescribing advice emphasizes clinician knowledge, judgment, current guidance, individualized needs, consent, and risk discussion in opioid agonist treatment.

Step 4 plan logistics and follow-up before agreeing

Confirm the clinic location, appointment type, arrival instructions, identification, privacy process, pharmacy coordination if applicable, and how future visits are scheduled. Ask how coverage or payment questions are handled without assuming a price or reimbursement result.

Request a written follow-up and contact plan. Know where routine questions go, how after-hours concerns are handled, and when emergency services are appropriate. Arrange safe transportation if the clinician advises it. Do not assume “monthly” means every person’s schedule is identical.

Ask what happens if work, travel, housing, phone access, health, other medications, substance use, pregnancy status, or treatment goals change. Clarify who updates the plan, which changes require a prompt clinical call, and how records move if care transfers. If family or another support person may be involved, discuss consent and privacy first. A useful plan assigns responsibilities: the patient knows whom to contact, the clinic explains monitoring and follow-up, and outside providers are connected through a confirmed process rather than a vague referral.

Use clear stop conditions

Pause the process if the clinician does not have an accurate medication and substance-use history, if eligibility has not been assessed, if consent questions remain unanswered, if the product monograph cannot be reviewed where needed, or if follow-up and urgent-contact instructions are unclear. Seek emergency help for an overdose or severe symptoms rather than waiting for a clinic callback.

Do not purchase, store, handle, or attempt to administer an injectable product outside the authorized clinical pathway. Do not use someone else’s medication or change another opioid treatment plan on your own.

Common preparation mistakes to avoid

• Using a search result as an eligibility decision.
• Withholding medication, alcohol, sedative, or opioid information.
• Changing current treatment before speaking with the prescriber.
• Assuming every clinic location offers the same service.
• Expecting one medication to replace counselling, harm reduction, or other supports automatically.
• Leaving without a routine, urgent, and emergency contact plan.
• Relying on old cost, coverage, dosing, or product-monograph details.
• Expecting a guaranteed recovery or symptom outcome.

Frequently asked questions

What is Sublocade used for?

It is extended-release buprenorphine used within clinician-managed treatment for opioid use disorder under its Canadian product monograph.

Can I inject Sublocade myself?

No. Health Canada describes it as administered by a healthcare provider in a medical setting.

Does everyone need the same preparation?

No. Assessment and planning depend on the person’s history, current treatment, risks, preferences, and clinician judgment.

Does Road To Recovery offer it at every location?

This article does not claim that. Confirm the specific service and intake pathway with the selected location.

Contact a clinic for an individualized assessment